EUSA Pharma to acquire Janssen Ireland’s Sylvant for $115m
EUSA Pharma has signed a definitive agreement to purchase global rights for Sylvant (siltuximab) drug from Janssen Sciences Ireland for…
EUSA Pharma has signed a definitive agreement to purchase global rights for Sylvant (siltuximab) drug from Janssen Sciences Ireland for…
Thank you for subscribing to Pharmaceutical Technology